The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbzena Regulatory News (ABZA)

  • There is currently no data for ABZA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Court sanction of the scheme of arrangement

10 Oct 2018 14:42

RNS Number : 6215D
Abzena PLC
10 October 2018
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

FOR IMMEDIATE RELEASE

 

10 October 2018

RECOMMENDED CASH ACQUISITION

of

Abzena plc

by

Astro BidCo Limited

 

A company wholly-owned by WCAS XII-Astro, L.P.

 

Court sanction of the scheme of arrangement

 

On 16 August 2018, the Boards of Abzena plc ("Abzena") and Astro BidCo Limited ("BidCo") announced that they had reached agreement on the terms of a recommended acquisition, pursuant to which BidCo will acquire the entire issued and to be issued share capital of Abzena (the "Acquisition") to be effected by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").

A scheme document sent or otherwise made available to shareholders of Abzena (the "Scheme Document"), containing further information on the Scheme, was published on 10 September 2018. The Scheme and its implementation were approved on 2 October 2018 at the Court Meeting and the General Meeting.

The Board of Abzena is pleased to announce that, at a hearing held earlier today, the Scheme was sanctioned by the Court.

The Scheme remains subject to the delivery to the Registrar of Companies of the Court Order made at the Court Hearing to sanction the Scheme. The Scheme is expected to become effective on 11 October 2018 (the "Effective Date") and a further announcement will be made at that time.

The last day and time for dealings in, and for registrations of transfers, of Abzena Shares is today, being 10 October 2018 at 6.00 p.m. (the "Scheme Record Time"), and trading in the Abzena Shares on AIM will be suspended with effect from 7.30 a.m. on 11 October.

It is expected that, subject to the Scheme becoming effective, the cancellation of trading of the Abzena Shares on AIM will take place at 7.00 a.m. on 12 October 2018.

By 7.00 a.m. on the business day following the Effective Date, share certificates in respect of Abzena Shares will cease to be valid and entitlements to Abzena Shares held within the CREST system will be cancelled.

Capitalised terms in this announcement ("Announcement"), unless otherwise defined, have the same meanings as set out in the Scheme Document.

END

Enquiries:

 

Abzena plc

Ken Cunningham (Chairman)

John Burt (Chief Executive Officer)

+44 (0) 1223 903 498

BidCo and WCAS

Jonathan M. Rather

+1 (212) 893 9500

N+1 Singer (Nominated adviser and broker to Abzena Plc)

Aubrey Powell

Ben Farrow

+44 (0) 20 7496 3000

Peel Hunt LLP (financial adviser to BidCo)

+44 (0) 20 7418 8900

Christopher Golden

Michael Nicholson

James Steel

Oliver Jackson

Instinctif Partners

Melanie Toyne Sewell

Rozi Morris

Alex Shaw

+44 (0) 20 7457 2020

 

 

IMPORTANT NOTICES

 

Nplus1 Singer Advisory LLP ("N+1 Singer"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting solely for Abzena as Nominated adviser and broker in relation to the matters referred to in this Announcement and for no one else. N+1 Singer will not be responsible to anyone other than Abzena for providing the protections afforded to its clients or for providing advice in relation to the contents of this Announcement or any arrangement referred to herein. N+1 Singer has given, and not withdrawn, its consent to the inclusion in this Announcement of the references to its name and the advice it has given to Abzena in the form and context in which they appear.

 

Peel Hunt LLP, which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for WCAS, the WCAS Fund and BidCo and for no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters referred to in this announcement and will not be responsible to anyone other than WCAS, the WCAS Fund and BidCo for providing the protections afforded to its clients or for providing advice in relation to the Acquisition or any other matter or arrangement referred to in this Announcement.

This Announcement is for information purposes only and is not intended to, and does not, constitute or form any part of, an offer to sell or an invitation to subscribe for or purchase any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of the securities referred to in this Announcement in any jurisdiction in contravention of applicable law.

 

Overseas jurisdictions

 

The release, publication or distribution of this Announcement in or into jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves about, and observe any applicable legal or regulatory requirements. Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of such jurisdiction. To the fullest extent permitted by applicable law, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person.

 

Neither this Announcement nor any of the documents relating to the Acquisition form or are intended to constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval pursuant to the Scheme or otherwise, in any jurisdiction in which such offer, invitation or solicitation is unlawful. This Announcement has been prepared for the purposes of complying with English law, the rules of the London Stock Exchange, the AIM Rules and the Code, and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside of England and Wales.

 

Further details in relation to Abzena Shareholders located in overseas jurisdictions are contained in the Scheme Document.

 

Publication on website and availability of hard copies

 

Pursuant to Rule 26.1 of the Code, a copy of this Announcement, will be made available, free of charge and subject to certain restrictions relating to persons in Restricted Jurisdictions, on Abzena's website at www.abzena.com by no later than 12 noon (London time) on the business day following the date of this Announcement. For the avoidance of doubt, neither the contents of such website nor the content of any website accessible from hyperlinks on such website is incorporated into, and do not form part of, this Announcement.

 

Pursuant to Rule 30.3 of the Code, a person so entitled may request a copy of this Announcement and/or any document incorporated by reference into this Announcement, free of charge. A person may also request that all future documents, announcements and information to be sent to that person in relation to the Acquisition should be sent by the party which publishes it in hard copy form. For persons who receive a copy of this Announcement in electronic form or via a website publication, a hard copy of this Announcement will not be sent unless so requested, by contacting N+1 Singer, One Bartholomew Lane, London EC2N 2AX, or by telephone on 0207 496 3000 (from within the UK) or +44 207 496 3000 (from outside the UK). If requested, copies will be provided, free of charge, within 2 business days of the request.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
SOAFFWFFSFASEDS
Date   Source Headline
11th Apr 20173:06 pmRNSDirector/PDMR Shareholding
7th Apr 20171:36 pmRNSGrant of options
5th Apr 20173:45 pmRNSResult of bookbuild
5th Apr 20177:00 amRNSProposed Placing of £25m
6th Mar 20177:00 amRNS'Abzena inside' product enters Phase II trial
3rd Mar 20177:00 amRNSPartner Halozyme to present poster at AACR
1st Mar 20177:00 amRNSMRC grant awarded to collaboration group
21st Feb 20177:01 amRNSAntibody manufacturing development agreement
21st Feb 20177:00 amRNSTrading and business update
8th Feb 20178:43 amEQSEdison issues outlook on Abzena
6th Feb 201710:55 amRNSTotal Voting Rights
31st Jan 201712:53 pmRNSHardman Research: ThioBridge deal update
24th Jan 20177:00 amRNSIssue of Equity
20th Jan 20177:00 amRNSThioBridge license agreement
9th Jan 20179:37 amRNSBlocklisting update
22nd Dec 20167:00 amRNSLicence agreement
13th Dec 20167:15 amRNSHardman Research: Opening new doors
30th Nov 20167:00 amRNSHalf year results
23rd Nov 20168:09 amRNS'Abzena inside' product study data to be presented
15th Nov 201612:42 pmRNSNotice of half year results
2nd Nov 20167:00 amRNSLicensed product candidate update
24th Oct 20167:00 amRNSSenior Executive Appointments
21st Oct 20167:00 amRNSLicensed product candidate update
22nd Sep 20169:30 amRNSLicensed product candidate update
19th Sep 20162:28 pmRNSChange of Nominated Adviser and Broker
14th Sep 20163:58 pmRNSEdison issues research update on Abzena (ABZA)
13th Sep 20163:41 pmRNSResult of AGM
13th Sep 20167:00 amRNSDirectorate Change
13th Sep 20167:00 amRNSAGM Business Update
16th Aug 201612:20 pmRNSDirector/PDMR Shareholding and Exercise of Options
9th Aug 20162:30 pmRNSNotice of AGM
28th Jul 201611:45 amRNSEdison issues research update on Abzena (ABZA)
25th Jul 20167:00 amRNSManufacturing agreement
14th Jul 201610:37 amRNSJoint venture with Baylor Research Institute
6th Jul 20163:58 pmRNSBlock Listing Update
27th Jun 20164:46 pmRNSDirector Dealings
24th Jun 20169:45 amRNSExercise of warrants
22nd Jun 201610:12 amRNSEdison issues research review on Abzena (ABZA)
15th Jun 20164:09 pmRNSAnnual Report and Accounts
14th Jun 20167:00 amRNSFull year results
26th May 20167:00 amRNSNotice of Results
5th Apr 20169:20 amRNSExercise of Employee Share Options
1st Apr 20169:48 amRNSExercise of Share Options and Director Dealings
16th Mar 20169:45 amRNSExercise of Employee Share Options
9th Mar 201612:47 pmRNSExercise of Employee Share Options
9th Mar 20167:00 amRNSBusiness update
8th Feb 20163:14 pmRNSExercise of employee share options
4th Feb 20162:33 pmRNSHolding(s) in Company
25th Jan 20167:00 amRNSSignificant licence deal for ThioBridgeT
18th Jan 20167:00 amRNSAntitope collaboration awarded European grant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.